Abstract
Glycated hemoglobin (HbA1c) is an indicator that reflects the level of glucose in the blood over the past 1-3 months. The main indications for its use are as follows: control of the course of diabetes mellitus (once in 3 months), control of the effectiveness of diabetes treatment, an indicator of the risk of developing complications of diabetes mellitus. The study of HbA1c allows evaluating the level of glycemia in a diabetes mellitus patient 60-90 days prior to the study. The study makes it possible to monitor the course of the disease and control the adequacy of the treatment. The study of HbA1c should be carried out to assess the risk of complications in a patient with diabetes mellitus.
Publisher
PANORAMA Publishing House
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference10 articles.
1. 1. Dedov I.I., Shestakova M.V., Maksimova M.A. Federalnaia tselevaia programma «Sakharnyi diabet» [Federal target program "Diabetes mellitus"]. // Moscow, 2002, 84 p. (In Russ.)
2. 2. Goldstein D.E., Little R.R. Bringing Order to Chaos: Standardizing the Hemoglobin A1c Assay. // Contemp Int Med 1997; 9(5): 27-32/
3. 3. Gonen B.A., Rubinstein A.H., Rochman H. et al. Hemoglobin A1: An Indicator of the Metabolic Control of Diabetic Patients. // The Lancet 1977, Oct 8; 2(804): 734-7.
4. 4. Koenig R.J., Peterson C.M., Kilo C. et al. Hemoglobin A1c as an Indicator of the Degree of Glucose Intolerance in Diabetes. // Diabetes 1976, 25(3): 230-2.
5. 5. Koenig R.J., Peterson C.M., Jones R.L. et al. Correlation of Glucose Regulation and Hemoglobin A1c in Diabetes Mellitus. // Engl J Med 1976, 295(8): 417-20.